Haploidentical Hematopoietic Stem Cell Transplantation With Early Antithymocyte Globulin and Low Dose Post-transplant Cyclophosphamide
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
Aim of this study is to investigate the effect of early administration of anti-thymocyte globulin and post-transplant low-dose cyclophosphamide in heploidentical hematopoietic stem cell transplantation.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients undergoing haploidentical hematopoietic stem cell transplantation with ATG and low-dose post-transplant cyclophosphamide conditioning at the department of pediatrics, Samsung Medical Center.
Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Hee Young Ju
hyju320@gmail.com
82-02-3410-0865
Backup
Min Suk Rheu
minsuk.rheu@sbri.co.kr
82-02-3410-3607
Time Frame
Start Date: 2023-05-29
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 20
Treatments
ATG/LD-PTCy group
Patients undergoing haploidentical hematopoietic stem cell transplantation with ATG and low-dose post-transplant cyclophosphamide conditioning at the department of pediatrics, Samsung Medical Center
Related Therapeutic Areas
Sponsors
Leads: Samsung Medical Center